Compared with other studies, the differences in outcomes between percutaneous coronary intervention (PCI) and coronary artery ...

For patients with out-of-hospital cardiac arrest (OHCA), the proportion receiving layperson bystander life support (BLS) has ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Individuals who present with acute myocardial infarction in the absence of standard modifiable cardiovascular risk factors (ie, SMuRF‐less) seem to have a significantly increased risk of mortality; ...

Antman discusses contemporary management of STEMI and an ACC.07 session he chaired entitled "ST Elevation Myocardial Infarction: The First 24 Hours." Dr. Smith: I'm Dr. Sidney Smith and with me is Dr.

I was 43 at the time. I had a busy job, with pressures and demands, trying to be a good dad and husband. But that’s the same ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

View all available purchase options and get full access to this article.

Semaglutide can help lower the risk of cardiovascular complications in people with diabetes, a new study has found.

A new sub-analysis of the SELECT trial data shows semaglutide 2.4 mg substantially reduces the burden of total cardiovascular ...